Sensus Healthcare Inc (SRTS) FinancialsSRTSSensus Healthcare Inc

Sensus Healthcare Inc (SRTS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Product Revenue, accounting for 58.8% of total sales, equivalent to $2.00M. Another important revenue stream is Service Revenue. Understanding this composition is critical for investors evaluating how SRTS navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Sensus Healthcare Inc maintains a gross margin of 33.58%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -138.86%, while the net margin is -382.05%. These profitability ratios, combined with a Return on Equity (ROE) of -34.83%, provide a clear picture of how effectively SRTS converts its operational activities into shareholder value.

In the context of the broader market, SRTS competes directly with industry leaders such as QTEX and NTRB. With a market capitalization of $57.95M, it holds a leading position in the sector. When comparing efficiency, SRTS's gross margin of 33.58% stands against QTEX's 0.69% and NTRB's 45.41%. Such benchmarking helps identify whether Sensus Healthcare Inc is trading at a premium or discount relative to its financial performance.

Sensus Healthcare has faced declining revenues, with Q2 2026 revenue at $2.3 million, down 68.5% year-over-year. The gross margin also decreased to 29.2% in Q1 2026, indicating challenges in maintaining profitability. Despite this, the company is adapting its strategy to focus on direct sales and recurring revenue models.